Fertility Drug Market, By Gender Type (Female Fertility Treatment and Male Fertility Treatment), By Treatment Type (Hormonal, In Vitro Fertilization(IVF), Intra Cytoplasmic Sperm Injection(ICSI), Intra Uterine Insemination(IUI, Alternative & Complementary Treatment), By Infertility Type (Problem With Ovulating, Unexplained Infertility, Blocked Or Damaged Tubes, Endometriosis, and Polycystic Ovarian Syndrome), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Trends, Analysis and Forecast Till 2029

Report Code: PMI11418 | Publish Date: March 2024 | No. of Pages: 178

Global Fertility Drug Market By Overview

Infertility is a circumstance affecting 1/5th to 1/6th couples in their reproductive age. Moreover, it is a deficiency that doesn’t compromise the physical integrity of the person and it is not life-threatening. Nevertheless, it has a negative impact on the development of the person, bringing frustration and weakening the personality. To overcome with such circumstances, fertility drugs are often used to augment the reproductive capability to increase the quality of sperms or eggs by improving the levels of certain hormones in the human body. In turn, it is expected to boost the demand for fertility drugs in the coming years. 

The fertility drugs market is mainly driven by factors such as changing human lifestyle, culture shift and rising incidence rate of obesity which is eventually responsible for the rising infertility rate among adults. Furthermore, the rise in the age of women to conceive and increasing sexually transmitted diseases (STDs) among people. Therefore, it is projected to gain more share value to the fertility drugs market during the forecast period. 

However, the high cost and risk related to the use of fertility drugs such as Ovarian Hyperstimulation Syndrome (OHS) is a major restraint of the  fertility drugs market.

The fertility drug market has been categorized based on gender type, treatment type, infertility type, and region. 

The gender type segment includes female fertility treatment and male fertility treatment. 

On the basis of treatment type, the fertility drug market has been divided into hormonal, in vitro fertilization (IVF), intra cytoplasmic sperm injection (ICSI), intra uterine insemination (IUI), alternative & complementary treatment. 

On the basis of the infertility type, the global market is fragmented problem with ovulating, unexplained infertility, blocked or damaged tubes, endometriosis, and polycystic ovarian syndrome.

By region, the target market has been segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. 

Some of the major players in the market of fertility drug include Berlex Laboratories, Inc., Baxter Healthcare Corp., Ferring Pharmaceutical Inc., Janssen Pharmaceutical Inc., Pfizer, Takeda Pharmaceutical co. ltd., and Procter & Gamble Pharmaceutical.

Global Fertility Drug Market By Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Gender Type
      • Market Snippet, By Treatment Type
      • Market Snippet, By Infertility Type
      • Market Snippet, By Region
    • Opportunity Map
  3. Market Dynamics Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
      • Drivers- Restraints Impact Analysis
      • PEST Analysis
      • Porter’s Five Forces Analysis
  4. Market Segmentation, By Gender Type, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Female Fertility Treatment
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Male Fertility Treatment
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  5. Market Segmentation, By Treatment Type, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Hormonal
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Alternative & Complementary Treatment
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • In Vitro Fertilization(IVF)
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Intra Cytoplasmic Sperm Injection(ICSI)
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Intra Uterine Insemination(IUI)
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

Market Segmentation, Infertility Type, 2018 – 2028, (US$ Mn)

  • Introduction
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
    • Y-o-Y Growth Analysis (%), 2019 – 2028
    • Segment Trends
  • Problem With Ovulating
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  • Unexplained Infertility
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  • Blocked Or Damaged Tubes
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  • Endometriosis
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  • Polycystic Ovarian Syndrome
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  1. Global Market, By Region, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Gender Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Treatment Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Infertility Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country Type, 2018 – 2028

Ø  U.S.

Ø  Canada

  • Latin America
    • Market Size and Forecast (US$ Mn), By Gender Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Treatment Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Infertility Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country Type, 2018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile

Ø  Rest of Latin America

  • Europe
    • Market Size and Forecast (US$ Mn), By Gender Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Treatment Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Infertility Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country Type, 2018 – 2028

Ø  Germany

Ø  UK

Ø  France

Ø  Russia

Ø  Italy

Ø  Switzerland

Ø  Sweden

Ø  Rest of Europe           

  • Asia Pacific
    • Market Size and Forecast (US$ Mn), By Gender Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Treatment Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Infertility Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country Type, 2018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

  • Middle East
    • Market Size and Forecast (US$ Mn), By Gender Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Treatment Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Infertility Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country Type, 2018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

  • Africa
    • Market Size and Forecast (US$ Mn), By Gender Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Treatment Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Infertility Type, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country Type, 2018 – 2028

Ø  South Africa

Ø  Central Africa

Ø  North Africa

  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Berlex Laboratories, Inc.*

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Baxter Healthcare Corp.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Ferring Pharmaceutical Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Janssen Pharmaceutical Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Pfizer

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Takeda Pharmaceutical co. ltd.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Procter & Gamble Pharmaceutical

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Analyst Views
  1. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The fertility drug market has been categorized based on gender type, treatment type, infertility type, and region.

Some of the major players in the market of fertility drug include Berlex Laboratories, Inc., Baxter Healthcare Corp., Ferring Pharmaceutical Inc., Janssen Pharmaceutical Inc., Pfizer, Takeda Pharmaceutical co. ltd., and Procter & Gamble Pharmaceutical.

The high cost and risk related to the use of fertility drugs such as Ovarian Hyperstimulation Syndrome (OHS) is a major restraint of the fertility drugs market.

The fertility drugs market is mainly driven by factors such as changing human lifestyle, culture shift and rising incidence rate of obesity which is eventually responsible for the rising infertility rate among adults.

North America is expected to account major market share as compared to that of other regions.